NovaBridge Biosciences American recorded an outflow of $20.6M in free cash flow in fiscal year 2025. This represents an increase of 60.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters NovaBridge Biosciences American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NBP Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
NBP Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More NovaBridge Biosciences American financials
Frequently Asked Questions
What was NovaBridge Biosciences American's free cash flow in fiscal year 2025?
NovaBridge Biosciences American recorded an outflow of $20.6M in free cash flow in fiscal year 2025.
How fast is NovaBridge Biosciences American's free cash flow growing?
NovaBridge Biosciences American (NBP) free cash flow rose by 60.9% year over year, from -$52.7M to -$20.6M in fiscal year 2025.
How has NovaBridge Biosciences American's free cash flow changed over the years?
Across the 7 fiscal years this page covers, NovaBridge Biosciences American (NBP) free cash flow went from -$126.4M in fiscal year 2019 to -$20.6M in fiscal year 2025.
What was NovaBridge Biosciences American's free cash flow in the most recent quarter?
NovaBridge Biosciences American (NBP) reported -$14.6M in free cash flow in Q4 2025. This represents a decrease of 32.8% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what NovaBridge Biosciences American (NBP) reported on that line in every period on record.